A clinical-stage biotechnology company focused on developing therapeutic and aesthetic applications of botulinum toxin–based compounds. Its research has targeted non‑surgical treatments for localized fat reduction and other dermatologic indications, placing it within the medical aesthetics segment o...
1 member of Congress has disclosed 2 trades in Neothetics, Inc. (NEOT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-17 | Roger W. Marshall | buy | $1K – $15K |
| 2017-10-17 | Roger W. Marshall | sell | $1K – $15K |